Nomura Asset Management Co. Ltd. Invests $442,000 in Doximity, Inc. $DOCS

Nomura Asset Management Co. Ltd. acquired a new stake in shares of Doximity, Inc. (NASDAQ:DOCS) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 7,202 shares of the company’s stock, valued at approximately $442,000.

Several other large investors also recently added to or reduced their stakes in the stock. Hantz Financial Services Inc. increased its position in shares of Doximity by 148.9% during the second quarter. Hantz Financial Services Inc. now owns 453 shares of the company’s stock worth $28,000 after acquiring an additional 271 shares during the period. National Bank of Canada FI bought a new position in Doximity in the first quarter worth approximately $33,000. Brooklyn Investment Group increased its holdings in Doximity by 70.7% during the 1st quarter. Brooklyn Investment Group now owns 746 shares of the company’s stock worth $43,000 after purchasing an additional 309 shares during the period. Smartleaf Asset Management LLC increased its holdings in Doximity by 176.0% during the 1st quarter. Smartleaf Asset Management LLC now owns 781 shares of the company’s stock worth $46,000 after purchasing an additional 498 shares during the period. Finally, Cullen Frost Bankers Inc. raised its position in Doximity by 29.7% during the 2nd quarter. Cullen Frost Bankers Inc. now owns 1,427 shares of the company’s stock valued at $88,000 after purchasing an additional 327 shares in the last quarter. 87.19% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director Kira Scherer Wampler sold 2,000 shares of the firm’s stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $66.44, for a total value of $132,880.00. Following the completion of the sale, the director owned 19,839 shares of the company’s stock, valued at $1,318,103.16. This trade represents a 9.16% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Timothy S. Cabral sold 20,000 shares of the business’s stock in a transaction on Wednesday, September 24th. The stock was sold at an average price of $75.00, for a total value of $1,500,000.00. Following the transaction, the director owned 3,221 shares in the company, valued at approximately $241,575. This trade represents a 86.13% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 32,000 shares of company stock worth $2,339,580. Insiders own 31.30% of the company’s stock.

Doximity Stock Performance

DOCS stock opened at $50.47 on Monday. Doximity, Inc. has a one year low of $46.04 and a one year high of $85.21. The firm has a market cap of $9.50 billion, a price-to-earnings ratio of 50.47, a PEG ratio of 4.10 and a beta of 1.36. The firm has a 50-day simple moving average of $65.37 and a two-hundred day simple moving average of $62.17.

Doximity (NASDAQ:DOCS) last issued its quarterly earnings data on Thursday, November 6th. The company reported $0.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.38 by $0.07. Doximity had a net margin of 36.60% and a return on equity of 21.75%. During the same period in the prior year, the company posted $0.30 EPS. The business’s revenue was up 23.2% compared to the same quarter last year. Doximity has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. As a group, equities analysts predict that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on DOCS. Bank of America raised Doximity from a “neutral” rating to a “buy” rating and increased their price target for the stock from $75.00 to $82.00 in a research report on Monday, October 27th. Canaccord Genuity Group dropped their target price on shares of Doximity from $67.00 to $58.00 and set a “hold” rating on the stock in a report on Monday, November 10th. Zacks Research lowered shares of Doximity from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 20th. KeyCorp upped their price target on shares of Doximity from $75.00 to $80.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 8th. Finally, Needham & Company LLC lifted their price objective on shares of Doximity from $67.00 to $75.00 and gave the company a “buy” rating in a report on Friday, August 8th. Two research analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, Doximity has a consensus rating of “Moderate Buy” and an average target price of $68.22.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.